Exosome‐mediated activation of toll‐like receptor 3 in... : Hepatology (original) (raw)

Liver Biology/Pathobiology

Exosome‐mediated activation of toll‐like receptor 3 in stellate cells stimulates interleukin‐17 production by γδ T cells in liver fibrosis

Seo, Wonhyo1; Eun, Hyuk Soo2,3; Kim, So Yeon1; Yi, Hyon‐Seung3; Lee, Young‐Sun4; Park, Seol‐Hee2,5; Jang, Mi‐Jin6; Jo, Eunjung2; Kim, Sun Chang6,7; Han, Yong‐Mahn6; Park, Keun‐Gyu8; Jeong, Won‐Il*,1,2

1Laboratory of Liver ResearchBiomedical Science and Engineering Interdisciplinary ProgramKAISTDaejeonRepublic of Korea

2Laboratory of Liver ResearchGraduate School of Medical Science and EngineeringKAISTDaejeonRepublic of Korea

3Department of Internal MedicineChungnam National University School of MedicineDaejeonRepublic of Korea

4Department of Internal MedicineKorea University College of MedicineSeoulRepublic of Korea

5Department of Internal MedicineCollege of Veterinary MedicineSeoul National UniversitySeoulRepublic of Korea

6Department of Biological SciencesKorea Advanced Institute of Science and TechnologyDaejeonRepublic of Korea

7Intelligent Synthetic Biology CenterDaejeonRepublic of Korea

8Department of Internal MedicineSchool of MedicineKyungpook National UniversityDaeguRepublic of Korea

*ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO:
Won‐Il Jeong, D.V.M., Ph.D.
Laboratory of Liver Research
Building E7, Room 8107
GSMSE/KAIST
291 Daehak‐ro, Yuseong‐gu
Daejeon 34141, Republic of Korea
Tel: +82‐42‐350‐4239
E‐mail: [email protected]

Abstract

During liver injury, hepatocytes secrete exosomes that include diverse types of self‐RNAs. Recently, self‐noncoding RNA has been recognized as an activator of Toll‐like receptor 3 (TLR3). However, the roles of hepatic exosomes and TLR3 in liver fibrosis are not yet fully understood. Following acute liver injury and early‐stage liver fibrosis induced by a single or 2‐week injection of carbon tetrachloride (CCl4), increased interleukin (IL)‐17A production was detected primarily in hepatic γδ T cells in wild‐type (WT) mice. However, liver fibrosis and IL‐17A production by γδ T cells were both significantly attenuated in TLR3 knockout (KO) mice compared with WT mice. More interestingly, IL‐17A‐producing γδ T cells were in close contact with activated hepatic stellate cells (HSCs), suggesting a role for HSCs in IL‐17A production by γδ T cells. In vitro treatments with exosomes derived from CCl4‐treated hepatocytes significantly increased the expression of IL‐17A, IL‐1β, and IL‐23 in WT HSCs but not in TLR3 KO HSCs. Furthermore, IL‐17A production by γδ T cells was substantially increased upon coculturing with exosome‐treated WT HSCs or conditioned medium from TLR3‐activated WT HSCs. However, similar increases were not detected when γδ T cells were cocultured with exosome‐treated HSCs from IL‐17A KO or TLR3 KO mice. Using reciprocal bone marrow transplantation between WT and TLR3 KO mice, we found that TLR3 deficiency in HSCs contributed to decreased IL‐17A production by γδ T cells, as well as liver fibrosis. Conclusion: In liver injury, the exosome‐mediated activation of TLR3 in HSCs exacerbates liver fibrosis by enhancing IL‐17A production by γδ T cells, which might be associated with HSC stimulation by unknown self‐TLR3 ligands from damaged hepatocytes. Therefore, TLR3 might be a novel therapeutic target for liver fibrosis. (Hepatology 2016;64:616‐631)